Objectives: This study aimed to assess the feasibility of pancreatic steatosis quantification by automated whole-volume measurement of the fat fraction of the pancreas on CT in comparison to magnetic resonance imaging (MRI) using proton-density fat fraction (PDFF) techniques. Methods: Fifty-nine patients who underwent both CT and MRI were analyzed. Automated whole-volume measurement of pancreatic fat on unenhanced CT was performed by a histogram analysis with local thresholding. Three sets of CT fat volume fraction (FVF) (%) values with thresholds of −30HU, −20HU and −10HU were compared to MR-FVF (%) values measured on a PDFF map. Results: The median −30HU CT-FVF, −20HU CT-FVF, −10HU CT-FVF and MR-FVF values of the pancreas were 8.6% (IQR, 11.3), 10.5% (IQR, 13.2), 13.4% (IQR, 16.1) and 10.9% (IQR, 9.7), respectively. The −30HU CT-FVF (%), −20HU CT-FVF (%) and −10HU CT-FVF (%) of the pancreas showed a significant positive correlation with the MR-FVF (%) of the pancreas (ρ = 0.898, p < 0.001, ρ = 0.905, p < 0.001, ρ = 0.909, p < 0.001, respectively). The −20HU CT-FVF (%) displayed reasonable agreement with the MR-FVF (%) with a low absolute fixed bias (mean difference, 0.32%; limit of agreement from −10.1 to 10.7%). Conclusion: The automated whole-volume measurement of the CT fat fraction of the pancreas using the threshold CT attenuation value of −20HU may be a feasible, noninvasive, and convenient technique for quantifying pancreatic steatosis. Advances in knowledge: CT-FVF value of the pancreas had a positive correlation with the MR-FVF value. The −20HU CT-FVF may be a convenient technique for quantifying pancreatic steatosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.